Dr. Isabel Feinstein, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10503 West Thunderbird Blvd, Suite 104, Sun City, AZ 85351 Phone: 623-975-1660 Fax: 623-584-4282 |
News Archive
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.
Charles Sherr, M.D., Ph.D., co-chair of Genetics and Tumor Cell Biology at St. Jude Children's Research Hospital and a Howard Hughes Medical Institute Investigator, has been awarded the distinction of American Association for the Advancement of Science (AAAS) Fellow. AAAS is the world's largest general scientific society.
Secretary of State Hillary Rodham Clinton, speaking at the NIH on Tuesday, "called on the world to create the first 'AIDS-free generation' by using antiviral drugs, condoms, circumcision and other approaches to stem the spread of HIV," the Washington Post reports.
CANCER RESEARCH UK, with its commercial arm Cancer Research Technology, today announce that they have entered into an innovative collaboration with AstraZeneca and MedImmune, its global biologics research and development arm, to establish a joint laboratory in Cambridge, UK.
A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines - followed by recycling through the liver - that could have important implications for developing treatments for intestinal diseases and for taking multiple medications at the same time.
› Verified 9 days ago